Retatrutide and Tirzepatide: Retatrutide and Tirzepatide are promising GLP-1 analogues currently under investigation in clinical trials for obesity treatment
Reduced appetite and meal skipping presents a paradoxical challengepatients may feel they're eating too little to warrant logging
[72] The company was a partner of the U.S
30 Protocol with Quick, Budget-Friendly Recipes, Mental Insights, and Proven Strategies to Lose Weight, Boost Energy, and Conquer Cravings
The study reported that 84% of the reports were from consumers, and 16% were from healthcare professionals
But Eimer emphasized that the findings should not discourage appropriate use of GLP-1 drugs, which have become increasingly popular for treating diabetes, obesity, cardiovascular disease and sleep apnea